These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35398097)

  • 1. Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5.
    Hsu MH; Johnson EF
    J Biol Chem; 2022 May; 298(5):101909. PubMed ID: 35398097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5.
    Hsu MH; Savas U; Johnson EF
    Mol Pharmacol; 2018 Jan; 93(1):14-24. PubMed ID: 29093019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes.
    Chanteux H; Rosa M; Delatour C; Nicolaï J; Gillent E; Dell'Aiera S; Ungell AL
    Drug Metab Dispos; 2020 Sep; 48(9):778-787. PubMed ID: 32532738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
    Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
    Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MD investigation on the differences in the dynamic interactions between the specific ligand azamulin and two CYP3A isoforms, 3A4 and 3A5.
    Liu S; Jing T; Jia R; Zhang JL; Bai FQ
    J Biomol Struct Dyn; 2024 Mar; ():1-10. PubMed ID: 38533567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insights into the Interaction of Cytochrome P450 3A4 with Suicide Substrates: Mibefradil, Azamulin and 6',7'-Dihydroxybergamottin.
    Sevrioukova IF
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4.
    Hsu MH; Johnson EF
    J Biol Chem; 2019 May; 294(20):8015-8022. PubMed ID: 30926609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.
    Stresser DM; Broudy MI; Ho T; Cargill CE; Blanchard AP; Sharma R; Dandeneau AA; Goodwin JJ; Turner SD; Erve JC; Patten CJ; Dehal SS; Crespi CL
    Drug Metab Dispos; 2004 Jan; 32(1):105-12. PubMed ID: 14709627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects of Clotrimazole on X-Ray Crystal Structures of Human Cytochromes P450 3A5 and 3A4.
    Hsu MH; Johnson EF
    Drug Metab Dispos; 2023 Dec; 51(12):1642-1650. PubMed ID: 37770228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
    Yamazaki H; Nakamoto M; Shimizu M; Murayama N; Niwa T
    Br J Clin Pharmacol; 2010 Jun; 69(6):593-7. PubMed ID: 20565450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of human cytochrome P450 3A4/5 in dexamethasone 6β-hydroxylation mediated by liver microsomes and humanized liver in chimeric mice metabolically suppressed with azamulin.
    Uehara S; Shimizu M; Suemizu H; Yamazaki H
    Drug Metab Pharmacokinet; 2023 Jun; 50():100504. PubMed ID: 37031476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.
    Xue L; Wang HF; Wang Q; Szklarz GD; Domanski TL; Halpert JR; Correia MA
    Chem Res Toxicol; 2001 May; 14(5):483-91. PubMed ID: 11368545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe.
    Wang H; Dick R; Yin H; Licad-Coles E; Kroetz DL; Szklarz G; Harlow G; Halpert JR; Correia MA
    Biochemistry; 1998 Sep; 37(36):12536-45. PubMed ID: 9730826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5.
    Okada Y; Murayama N; Yanagida C; Shimizu M; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 2009 Jan; 37(1):18-23. PubMed ID: 18948377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
    Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
    Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential oxidation of mifepristone by cytochromes P450 3A4 and 3A5: selective inactivation of P450 3A4.
    Khan KK; He YQ; Correia MA; Halpert JR
    Drug Metab Dispos; 2002 Sep; 30(9):985-90. PubMed ID: 12167563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
    Lin HL; Zhang H; Medower C; Hollenberg PF; Johnson WW
    Drug Metab Dispos; 2011 Feb; 39(2):345-50. PubMed ID: 21068193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of catalytic properties of cytochromes P450 3A4 and 3A5 by molecular docking simulation.
    Niwa T; Yasumura M; Murayama N; Yamazaki H
    Drug Metab Lett; 2014; 8(1):43-50. PubMed ID: 24484539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activities.
    Gillam EM; Guo Z; Ueng YF; Yamazaki H; Cock I; Reilly PE; Hooper WD; Guengerich FP
    Arch Biochem Biophys; 1995 Mar; 317(2):374-84. PubMed ID: 7893152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.